MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Revenue
$403,430M
Net Income
$4,762M
Net Profit Margin
1.18%
EPS
$38.38
Unit: Million (M) dollars
Revenue Breakdown
    • North American Pharmaceutical Se...
    • Oncology And Multispecialty Segm...
    • Medical Surgical Solutions Segme...
    • Others

Income Statement
2026-03-31
2025-03-31
2024-03-31
2023-03-31
Revenues
403,430 359,051 308,951 276,711
Cost of sales
388,880 345,728 296,123 264,353
Gross profit
14,550 13,323 12,828 12,358
Selling, distribution, general, and administrative expenses
8,096 8,507 8,657 7,776
Claims and litigation charges, net
3 -108 -147 8
Goodwill impairment charges
NaN NaN NaN 0
Restructuring, impairment, and related charges, net
245 286 115 209
Total operating expenses
8,338 8,901 8,919 7,977
Operating income
6,212 4,422 3,909 4,381
Other income, net
236 202 132 497
Interest expense
247 265 NaN NaN
Income before income taxes
6,201 NaN NaN NaN
Loss on debt extinguishment
NaN NaN 0 0
Interest expense
NaN NaN 252 248
Income from continuing operations before income taxes
NaN 4,359 3,789 4,630
Income tax expense
1,102 878 629 905
Income from continuing operations
NaN 3,481 3,160 3,725
Loss from discontinued operations, net of tax
NaN 0 0 -3
Net income
5,099 3,481 3,160 3,722
Net income attributable to noncontrolling interests
337 186 158 162
Net income attributable to mckesson corporation
4,762 3,295 3,002 3,560
Basic EPS
38.55 25.86 22.54 25.23
Diluted EPS
38.38 25.72 22.39 25.03
Basic Average Shares
123,600,000 127,400,000 133,200,000 141,100,000
Diluted Average Shares
124,100,000 128,100,000 134,100,000 142,200,000
Unit: Million (M) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

North AmericanPharmaceutical...$336,652M Oncology AndMultispecialty...$48,423M Medical SurgicalSolutions...$11,507M (1.06%↑ Y/Y)OperatingSegments-Prescription Technology...$5,805M (11.29%↑ Y/Y)Material ReconcilingItems$1,043M Revenues$403,430M (12.36%↑ Y/Y)Gross profit$14,550M (9.21%↑ Y/Y)Cost of sales$388,880M (12.48%↑ Y/Y)Operating income$6,212M (40.48%↑ Y/Y)Other income, net$236M (16.83%↑ Y/Y)Total operatingexpenses$8,338M (-6.33%↓ Y/Y)Claims and litigationcharges, net$3M (102.78%↑ Y/Y)Income before incometaxes$6,201M Interest expense$247M (-6.79%↓ Y/Y)Selling, distribution,general, and...$8,096M (-4.83%↓ Y/Y)Restructuring, impairment, andrelated charges, net$245M (-14.34%↓ Y/Y)Net income$5,099M (46.48%↑ Y/Y)Income tax expense$1,102M (25.51%↑ Y/Y)Net incomeattributable to mckesson...$4,762M (44.52%↑ Y/Y)Net incomeattributable to...$337M (81.18%↑ Y/Y)

mck_logo_blue-svg

MCKESSON CORP (MCK)

mck_logo_blue-svg

MCKESSON CORP (MCK)